| Financial Year |
March 31 2023 |
| Monetary Funds |
603,487,310.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
56,026,261.36 |
| Accounts Receivable |
1,647,983,689.94 |
| Advances to Suppliers |
154,873,606.16 |
| Other Receivables |
191,999,952.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
282,647,869.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
23,575,935.91 |
| Other Current Assets |
61,902,047.92 |
| Total Current Assets |
4,297,823,572.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
38,296,460.42 |
| Long-term Equity Investment |
346,408,627.63 |
| Investment Properties |
52,371,395.10 |
| Fixed Assetes |
3,311,033,520.17 |
| Under-construction Projects |
45,508,655.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,510,795,672.82 |
| R&D expenses |
9,826,224.33 |
| Goodwill |
169,785.97 |
| Long-Term Deferred and Prepaid Expenses |
83,740,234.41 |
| Deferred Income Tax Assets |
143,918,501.02 |
| Other Non-Current Assets |
75,794,239.58 |
| Sub-Total of Non-Current Assets |
5,903,768,729.83 |
| Total Assets |
10,201,592,302.60 |
| Short-Term Loans |
906,765,787.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,207,990.16 |
| Accounts Payable |
1,612,611,565.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,655,054.37 |
| Taxes Payable |
35,204,055.92 |
| Interest Payable |
-- |
| Dividend Payable |
3,595,073.28 |
| Other payables |
252,886,278.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
148,515,222.50 |
| Other Current Liabilities |
20,761,709.78 |
| Sub-Total of Current Liabilities |
3,316,417,251.94 |
| Long-term Loans |
1,172,277,061.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
711,733.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
39,637,895.37 |
| Deferred Income Tax Liabilities |
64,357,119.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,323,792,904.59 |
| Total Liabilities |
4,640,210,156.53 |
| Paid-In Capital(Or Share Stock) |
780,816,890.00 |
| Capital Surplus |
2,989,160,758.76 |
| Surplus Reserve |
244,677,071.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
963,993,059.64 |
| Minority Stockholder's Interest |
457,147,821.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,104,234,324.10 |
| Owner's Equity（Stockholder's Equity） |
5,561,382,146.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,201,592,302.60 |
